{"id":"https://openalex.org/W2587790927","doi":"https://doi.org/10.1182/blood.v112.11.4975.4975","title":"Potent Anti-Cancer Activity of Anti-NTB-a Monoclonal Antibodies in Preclinical Leukemia and Lymphoma Models","display_name":"Potent Anti-Cancer Activity of Anti-NTB-a Monoclonal Antibodies in Preclinical Leukemia and Lymphoma Models","publication_year":2008,"publication_date":"2008-11-16","ids":{"openalex":"https://openalex.org/W2587790927","doi":"https://doi.org/10.1182/blood.v112.11.4975.4975","mag":"2587790927"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v112.11.4975.4975","doi":"https://doi.org/10.1182/blood.v112.11.4975.4975","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.4975.4975","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004641141","display_name":"Wouter Korver","orcid":"https://orcid.org/0009-0003-1869-2631","observed_orcids":["https://orcid.org/0009-0003-1869-2631"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wouter Korver","raw_affiliation_strings":["Discovery Research, Nuvelo, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Research, Nuvelo, Inc., San Carlos, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022367860","display_name":"Xiaoxian Zhao","orcid":"https://orcid.org/0000-0002-8761-3170","observed_orcids":["https://orcid.org/0000-0002-8761-3170"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaoxian Zhao","raw_affiliation_strings":["Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079796646","display_name":"Shweta Singh","orcid":"https://orcid.org/0000-0001-9125-5727","observed_orcids":["https://orcid.org/0000-0001-9125-5727"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shweta Singh","raw_affiliation_strings":["Discovery Research, Nuvelo, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Research, Nuvelo, Inc., San Carlos, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001036358","display_name":"C\u00e9cile Pardoux","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cecile Pardoux","raw_affiliation_strings":["Discovery Research, Nuvelo, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Research, Nuvelo, Inc., San Carlos, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075572915","display_name":"Ishita Barman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ishita Barman","raw_affiliation_strings":["Nuvelo, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuvelo, Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088648008","display_name":"Gerard Aguilar","orcid":"https://orcid.org/0000-0003-4198-5769","observed_orcids":["https://orcid.org/0000-0003-4198-5769"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerard Aguilar","raw_affiliation_strings":["Discovery Research, Nuvelo, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Research, Nuvelo, Inc., San Carlos, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048284696","display_name":"Jingsong Zhao","orcid":"https://orcid.org/0000-0002-0409-6164","observed_orcids":["https://orcid.org/0000-0002-0409-6164"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jingsong Zhao","raw_affiliation_strings":["Discovery Research, Nuvelo, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Research, Nuvelo, Inc., San Carlos, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027080346","display_name":"Eric D. Hsi","orcid":"https://orcid.org/0000-0001-8623-4067","observed_orcids":["https://orcid.org/0000-0001-8623-4067"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Hsi","raw_affiliation_strings":["Clinical Pathology, Cleveland Clinic, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pathology, Cleveland Clinic, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109899780","display_name":"Arie Abo","orcid":"https://orcid.org/0009-0006-7198-028X","observed_orcids":["https://orcid.org/0009-0006-7198-028X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arie Abo","raw_affiliation_strings":["Discovery Research, Nuvelo, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Research, Nuvelo, Inc., San Carlos, CA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.35290864,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"112","issue":"11","first_page":"4975","last_page":"4975"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.009399999864399433,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9929999709129333},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.7940000295639038},{"id":"https://openalex.org/keywords/b-cells","display_name":"B cells","score":0.7229999899864197},{"id":"https://openalex.org/keywords/complement-dependent-cytotoxicity","display_name":"complement-dependent cytotoxicity","score":0.8980000019073486},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.996999979019165},{"id":"https://openalex.org/keywords/chimeric-antibodies","display_name":"chimeric antibodies","score":0.7409999966621399},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9049999713897705},{"id":"https://openalex.org/keywords/lymphoma-xenografts","display_name":"lymphoma xenografts","score":0.9430000185966492},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.5830000042915344},{"id":"https://openalex.org/keywords/lymphodepletion","display_name":"lymphocyte depletion","score":0.5509999990463257}],"concepts":[{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.7985898852348328},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.7882312536239624},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7271350026130676},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.7224507331848145},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5733277797698975},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5507477521896362},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5000863075256348},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.4845942258834839},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4660089612007141},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4654211699962616},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.46239742636680603},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.45645734667778015},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4184485673904419},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.41450974345207214},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25689172744750977},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.15522947907447815},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14137667417526245},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.08721405267715454},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v112.11.4975.4975","doi":"https://doi.org/10.1182/blood.v112.11.4975.4975","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.4975.4975","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8100000023841858,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2980138738","https://openalex.org/W2027576648","https://openalex.org/W2559956533","https://openalex.org/W2055917047","https://openalex.org/W2557984292","https://openalex.org/W2502545825","https://openalex.org/W2408879624","https://openalex.org/W7098012612","https://openalex.org/W2030454785","https://openalex.org/W2309133506"],"abstract_inverted_index":{"Abstract":[0],"NTB-A":[1,30,42,144],"is":[2],"a":[3,25,107,111,115,132,146],"CD2-related":[4],"cell":[5,60,87,137],"surface":[6],"protein":[7],"expressed":[8],"on":[9,135],"lymphoid":[10],"cells":[11,79],"including":[12],"B-lymphocytes":[13],"from":[14,67,81],"Chronic":[15],"Lymphocytic":[16],"Leukemia":[17],"(CLL)":[18],"and":[19,31,52,62,69,84,158],"lymphoma":[20,70,86,101],"patients.":[21,71],"We":[22],"have":[23],"generated":[24],"series":[26],"of":[27,118,127,156],"mAbs":[28,40,91],"against":[29,77,98],"assessed":[32],"their":[33],"therapeutic":[34],"potential":[35],"in":[36,46,59,103,124],"preclinical":[37],"models.":[38],"Selected":[39],"to":[41,96],"were":[43],"further":[44],"tested":[45],"functional":[47],"Complement":[48],"Dependent":[49,54],"Cytotoxicity":[50],"(CDC)":[51],"Antibody":[53],"Cellular":[55],"Cytotoxicty":[56],"(ADCC)":[57],"assays":[58],"lines":[61],"B":[63,78,85],"lymphocytes":[64,129],"freshly":[65],"isolated":[66,80],"CLL":[68,82],"Potent":[72],"cytotoxic":[73],"activity":[74,94],"was":[75],"demonstrated":[76,92],"patients":[83],"lines.":[88],"Chimeric":[89],"anti-NTB-A":[90,120],"anti-tumor":[93],"equal":[95],"rituximab":[97],"CA46":[99],"human":[100],"xenografts":[102],"nude":[104],"mice":[105],"at":[106],"low":[108],"dose.":[109],"In":[110],"chimpanzee":[112],"safety":[113,152],"study,":[114],"single":[116],"dose":[117],"lead":[119],"mAb":[121],"994.1":[122],"resulted":[123],"near-complete":[125],"depletion":[126],"peripheral":[128],"while":[130],"having":[131],"minimal":[133],"effect":[134],"T":[136],"activation.":[138],"Taken":[139],"together,":[140],"these":[141],"results":[142],"demonstrate":[143],"as":[145],"promising":[147],"target":[148],"with":[149],"an":[150],"acceptable":[151],"profile":[153],"for":[154],"immunotherapy":[155],"leukemia":[157],"lymphomas.":[159]},"counts_by_year":[],"updated_date":"2026-09-23T05:00:35.095934","created_date":"2017-02-24T00:00:00"}